American Realty Capital Healthc (HCT) 13.11

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
American Realty Capital Healthc (HCT) 13.11 $HCT

American Realty Capital Healthcare Trust III, Inc. Announces Review of Strategic Alternatives
PR Newswire - Fri Apr 29, 4:20PM CDT
American Realty Capital Healthcare Trust III, Inc. ("HT III" or the "Company", a publicly registered, non-traded real estate investment trust, today announced that the Company's Board of Directors, led by its independent directors, has initiated a strategic review process to identify, examine, and consider a range of strategic alternatives available to the Company with the objective of maximizing long term shareholder value.
HCT: 13.11 (+0.09)

Fitch Affirms Ventas at 'BBB+' & Rates 2026 Notes 'BBB+'; Withdraws NHP's Ratings
BusinessWire - Thu Jul 16, 1:13PM CDT
Fitch Ratings has affirmed the ratings of Ventas, Inc. (NYSE: VTR) and its subsidiaries, including the company's Issuer Default Rating (IDR), at 'BBB+'. The Rating Outlook is Stable. A full list of rating actions follows at the end of this release.
VTR: 73.41 (+1.08), HCT: 13.11 (+0.09)

ARC Healthcare Trust II Announces Intent to List
PR Newswire - Wed Mar 18, 5:04AM CDT
American Realty Capital Healthcare Trust II, Inc. ("Healthcare Trust II" or the "Company" today announced that it intends to file an application to list its common stock on a national stock exchange under the symbol "HTI," and, subject to approval, anticipates that its common stock will begin trading on such exchange during the third quarter of 2015. Concurrent with the listing, the Company intends to change its name to "Healthcare Trust, Inc."
HCT: 13.11 (+0.09)

AR Capital Sponsored Program Completes First Full-Cycle Liquidity Event of 2015
PR Newswire - Mon Feb 02, 5:00AM CST
AR Capital, LLC ("AR Capital" today announced the successful completion of a previously announced transaction for its sponsored program, American Realty Capital Healthcare Trust, Inc. ("ARC Healthcare" in a stock and cash transaction valued at $3.2 billion, or $13.12 per ARC Healthcare share.
HCT: 13.11 (+0.09)

Ventas Completes Acquisition of HCT
BusinessWire - Fri Jan 16, 6:42PM CST
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company" and American Realty Capital Healthcare Trust, Inc. (NASDAQ: HCT) ("HCT" today announced that Ventas has completed its previously announced acquisition of HCT.
VTR: 73.41 (+1.08), HCT: 13.11 (+0.09)

Ventas Nears American Realty Merger, Stockholders Okay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 16, 11:10AM CST
The proposed merger of American Realty Capital (HCT), with and into a wholly owned subsidiary of Ventas (VTR) has got shareholders' approval.
MPW: 15.21 (+0.16), OHI: 36.63 (+0.50), VTR: 73.41 (+1.08), HCT: 13.11 (+0.09)

American Realty Capital Healthcare Trust to merge with Ventas following stockholders' approval
M2 - Fri Jan 16, 6:35AM CST
American Realty Capital Healthcare Trust (NasdaqGS:HCT), that has a portfolio of medical office buildings, seniors housing and select hospital and post-acute care properties, reported on Thursday the receipt of approval of its merger with and into a wholly owned subsidiary of Ventas (VTR) under an Agreement and Plan of Merger.
HCT: 13.11 (+0.09)

Stockholders of American Realty Capital Healthcare Trust Approve Merger with Ventas
PR Newswire - Thu Jan 15, 4:45PM CST
American Realty Capital Healthcare Trust, Inc. (NASDAQ: HCT) ("HCT", a publicly traded real estate investment trust ("REIT", announced today that, at a special meeting of its stockholders held earlier today, the merger of HCT with and into a wholly owned subsidiary of Ventas, Inc. (NYSE: VTR) ("Ventas", pursuant to the Agreement and Plan of Merger, dated as of June 1, 2014, as amended, by and among Ventas, HCT, Stripe Sub, LLC, Stripe OP, LP and American Realty Capital Healthcare Trust Operating Partnership, L.P. was approved, with approximately 97.7 percent of the votes cast (representing approximately 65.5 percent of HCT's shares outstanding) voting to approve the merger.
VTR: 73.41 (+1.08), HCT: 13.11 (+0.09)

Ventas and American Realty Capital Healthcare Trust, Inc. Announce Definitive Election Deadline for HCT Stockholders to Make an Election to Receive Cash or Stock in the Merger
BusinessWire - Wed Jan 07, 3:24PM CST
Ventas, Inc. (NYSE: VTR) ("Ventas" and American Realty Capital Healthcare Trust, Inc. (NASDAQ: HCT) ("HCT" today announced that the definitive election deadline for HCT's stockholders to make an election to receive cash consideration, stock consideration or a combination of both, subject to proration, for their shares of HCT common stock upon completion of the merger of HCT with and into a wholly owned subsidiary of Ventas, pursuant to the Agreement and Plan of Merger, dated as of June 1, 2014, as amended (the "Merger Agreement", by and among Ventas, HCT, Stripe Sub, LLC, Stripe OP, LP and American Realty Capital Healthcare Trust Operating Partnership, L.P., will be 5:00 p.m. Eastern Time on January 14, 2015 (the "Election Deadline".
VTR: 73.41 (+1.08), HCT: 13.11 (+0.09)

Ventas announces prorated dividend of USD0.79 per share related to the acquisition of American Realty Capital Healthcare Trust Inc
M2 - Tue Jan 06, 5:57AM CST
A real estate investment trust, Ventas Inc's (NYSE:VTR) board of directors approved a prorated dividend of USD0.79 per share on the company's common stock that is conditioned upon the completion of its pending acquisition of American Realty Capital Healthcare Trust Inc (NASDAQ:HCT) (HCT) with and into a wholly owned subsidiary of Ventas (the merger), the company reported today.
VTR: 73.41 (+1.08), HCT: 13.11 (+0.09)

Ventas Declares Prorated Dividend in Connection with Acquisition of American Realty Capital Healthcare Trust, Inc.
BusinessWire - Mon Jan 05, 7:45PM CST
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company" announced today that its Board of Directors has declared a prorated dividend on the Company's common stock, conditioned upon the completion of its pending acquisition of American Realty Capital Healthcare Trust, Inc. (NASDAQ: HCT) ("HCT" pursuant to a merger of HCT with and into a wholly owned subsidiary of Ventas (the "Merger".
VTR: 73.41 (+1.08), HCT: 13.11 (+0.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stocks Jump Ahead of Critical Inflation Reports

Updated Category News Views 129

Stocks Lift as Wall Street Awaits Inflation Data Every trader's favorite game—speculation—returns as major U.S. stock benchmarks kick off Monday with some gusto. The S&P 500, Nasdaq Composite, Dow Jones Industrial Average, and Russell 2000 all saw gains in the early morning session, signaling positive vibes across the board. Numbers don't lie, folks: The S&P climbed...

Continue Reading
AutoMobility LA: Autonomous Tech's Big Leap

Updated Category News Views 61

Rolling Toward an Autonomous Future Alright, gearheads and tech buffs alike, gather 'round for a ride into the future of road travel. AutoMobility LA, a brainchild of the Los Angeles Auto Show, is revving up to give us a sneak peek into the era where cars don't just roll—they think. "The future's not about who's behind the wheel, but who's crafting the brain of the...

Continue Reading
Hyperscale Data Plans Major Stock Exchange Deal

Updated Category News Views 80

Hyperscale's Bold Move: Exchange Offer Hits the Market Man, when a company believes its market value is out of whack, you get moves like this. Hyperscale Data, strutting under ticker symbol NYSE:GPUS, is swinging for the fences with an exchange offer, aiming to mop up $50 million worth of its common stock with a sweet deal that’s sure to grab any investor's attention....

Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 101

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
Chipotle's BOGO Promo Returns: Tattoos Boost Sales

Updated Category News Views 101

Chipotle's BOGO Charade: A Tattooed Affair You've got to hand it to Chipotle—they know how to turn heads and wallets with their quirky promotions. The upcoming 'Tatted Like a Chipotle Bag' offer is a prime example of how they ride the cultural zeitgeist as they gear up for another record-breaking day on Friday, November 13. And seriously, with tattoos in play, they're...

Continue Reading
Energenesis Tackles Space Anemia with ATP Boost

Updated Category News Views 84

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Continue Reading
Guizhou's Mountain Conference Pushes Tourism Evolution

Updated Category News Views 28

Climbing High: Guizhou's Tourism Summit The 2026 International Conference of Mountain Tourism and Outdoor Sports in Guizhou has kicked off with a heartfelt focus on merging natural allure with modern tourism. This isn't just another gathering; it's a powerhouse of international dialogue harbored right in China's dramatic landscape. Building on Unique Natural Assets...

Continue Reading
Bybit Shines at Web Summit 2026 as AI Takes Center Stage

Updated Category News Views 95

Financial Revolution: Bybit Steals the Spotlight Ever been to a tech show where financial bigwigs mingle with code geeks? Well, that's exactly the scene unfolding at the famed Web Summit 2026, with Bybit throwing down the gauntlet as an official partner. The MEO Arena in Lisbon is buzzing more than a stock ticker on a rollercoaster day, as Bybit flaunts its wares to a...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 97

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading
NSAP's First Board Aims to Revolutionize Autism Care

Updated Category News Views 61

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Seafood Summit 2026: Deepening Industry Insights

Updated Category News Views 30

Gearing Up for the 2026 Responsible Seafood Summit In these jittery market waters and unpredictable times, the seafood industry is gathering its heavyweights in Bangkok this September. The Global Seafood Alliance (GSA), along with The Center for Responsible Seafood, is rolling out the red carpet for the 25th Responsible Seafood Summit at the plush Shangri-La Bangkok. Mark...

Continue Reading
Investigation into DeFi Technologies: What Investors Should Know

Updated Category News Views 106

Understanding the Investigation into DeFi Technologies Faruqi & Faruqi, LLP, a reputable name in securities litigation, is currently looking into claims on behalf of investors associated with DeFi Technologies, Inc. This emerging tech company, identified on the NASDAQ under the ticker DEFT, has become the subject of scrutiny as they deal with various shareholder concerns....

Continue Reading
Mid-Cap Stock Highlights: Akero, Brinker, and Viavi Surge

Updated Category News Views 109

Top Performing Mid-Cap Stocks The mid-cap sector has witnessed remarkable movements lately, with several stocks showing impressive gains. Investors are keen to track these stocks, as their performance can significantly influence portfolios. Below we explore the notable performers. Akero Therapeutics Leads the Pack Akero Therapeutics, Inc. (NASDAQ: AKRO) recently made...

Continue Reading
Sigma Defense Joins NSA's Trusted Integrator Roster

Updated Category News Views 15

A Big League Certification You know, when a defense company like Sigma Defense Systems lands the Trusted Integrator badge from the NSA, it’s no small potatoes. This isn’t just some badge of merit; it’s essentially an entry to the big leagues in terms of secure tech integration. We’re talking about handling the crown jewels of national security data with commercial...

Continue Reading
Clorox Delivers Strong Q1 Results Amid Cyber Challenges

Updated Category News Views 89

Clorox Demonstrates Strong Performance in Q1 Recently, Clorox (NYSE: CLX) has showcased impressive financial results for the first quarter, leading Jefferies to maintain a Buy rating on the stock while slightly raising the price target to $188 from $187. This upward adjustment illustrates the firm's confidence in Clorox's effective management and resilience following the...

Continue Reading